Basic & Clinical Medicine ›› 2025, Vol. 45 ›› Issue (2): 183-188.doi: 10.16352/j.issn.1001-6325.2025.02.0183

• Original Articles • Previous Articles     Next Articles

Establishment and preliminary study of four patient-derived primary breast cancer cell lines

LUO Yubei1, HUANG Jianjun2, YANG Wenxiu1, ZHANG Junhong1, LI Jing4, Robert Chunhua ZHAO4*, DOU Xiaowei3*   

  1. 1. Department of Pathology;
    2. Department of Breast Surgery;
    3. Clinical Research Center, the Affiliated Hospital of Guizhou Medical University, Guiyang 550004;
    4. Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Center for Excellence in Tissue Engineering, Beijing Key Laboratory of New Drug Development and Clinical Trial of Stem Cell Therapy (BZ0381), Beijing 100005, China
  • Received:2024-06-19 Revised:2024-09-27 Online:2025-02-05 Published:2025-01-17
  • Contact: *zhaochunhua@vip.163.com;douxw@gmc.edu.cn

Abstract: Objective To establish primary breast cancer cell lines from patient tissues and offer a new cancer cell model for basic research. Methods Breast cancer biopsy tissues were digested with type Ⅱ collagenase and cultured in BCMI medium. When the cells proliferated rapidly, the medium was switched to DMEM. STR genotyping was performed to identify specific genetic markers of the four primary breast cancer cell lines. Colony expansion assays and sphere formation assays were conducted to analyze its tumorigenicity. Real-time PCR and Western blot experiments were used to analyze the expression of the epithelial-mesenchymal transition (EMT) molecule markers. Migration and invasion assays were performed to assess the metastatic potential of the primary breast cancer cells. Results We established four primary breast cancer cell lines: BC25#, BC51#, BC56#, and BC57#. These cell lines were cultured in DMEM medium, passaged multiple times and tagged with details about their clinical past. STR genotyping identified specific genetic markers for each of the four primary breast cancer cell lines. Clonogenic and sphere formation assays revealed that the four lines have a stronger tumor-forming capability compared to the classic breast cancer cell line T-47D. Real-time PCR and Western blot experiments showed that, compared to T-47D, the four primary breast cancer cell lines have decreased E-cadherin expression and increased vimentin expression. Migration and invasion assays indicated that BC25# had a higher metastatic potential than the traditional breast cancer cell line T-47D. Conclusions Four primary breast cancer cell lines, BC25#, BC51#, BC56# and BC57# are successfully established, which may act as new cancer cell model for laboratory research of breast cancer.

Key words: primary breast cancer cell lines, basic research, new cancer cell model

CLC Number: